Insider · CIK 0001477384
John A Orwin
director
Files at ANAB (ANAPTYSBIO, INC), TVTX (Travere Therapeutics, Inc.), CRGX (CARGO Therapeutics, Inc.), TRAX (First Tracks Biotherapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +1,300 | $0.00 | $0 | 17,995 | 25 d ago |
| Sep 15, 2026 | TRAX First Tracks Biotherapeutics, Inc. | MOption exercise Common Stock | +1,300 | $0.00 | $0 | 17,995 | 25 d ago |
| Sep 15, 2026 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -1,300 | $0.00 | $0 | 0 | 25 d ago |
| Sep 15, 2026 | TRAX First Tracks Biotherapeutics, Inc. | MOption exercise Restricted Stock Unitderivative | -1,300 | $0.00 | $0 | 0 | 25 d ago |
| Sep 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +1,300 | $0.00 | $0 | 10,665 | Sep 17, 2025 |
| Sep 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -1,300 | $0.00 | $0 | 1,300 | Sep 17, 2025 |
| Jun 18, 2025 | CRGX CARGO Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 20, 2025 |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Common Stock | +6,030 | $0.00 | $0 | 9,365 | Jun 17, 2025 |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | MOption exercise Restricted Stock Unitderivative | -6,030 | $0.00 | $0 | 0 | Jun 17, 2025 |
| May 15, 2025 | TVTX Travere Therapeutics, Inc. | AGrant or award Common Stock | +6,500 | $0.00 | $0 | 35,375 | May 16, 2025 |
| May 15, 2025 | TVTX Travere Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +19,500 | $0.00 | $0 | 19,500 | May 16, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Stock Option (right to buy)derivative | +16,510 | $0.00 | $0 | 16,510 | Jan 7, 2025 |
| Jan 7, 2025 | ANAB ANAPTYSBIO, INC | AGrant or award Restricted Stock Unitderivative | +6,030 | $0.00 | $0 | 6,030 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.